Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
249.03Price to Sales
VS
Market
Sector
Industry
History
$ 13.67Close
$ 3.59 - $ 14.97 52-Week Range
Ticker Information
Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAVALO THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AVTX - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 109.82M | 249.03 | $ 441K |
| 3/31/2025 | $ 43.31M | 98.21 | $ 441K |
| 12/31/2024 | $ 87.72M | 198.92 | $ 441K |
| 9/30/2024 | $ 134.19M | 163.64 | $ 820K |
| 6/30/2024 | $ 10.24M | 12.69 | $ 807K |
| 3/31/2024 | $ 11.19M | 7.72 | $ 1.45M |
| 12/31/2023 | $ 22.49M | 11.69 | $ 1.92M |
| 9/30/2023 | $ 18.85M | 8.38 | $ 2.25M |
| 6/30/2023 | $ 4.01M | 0.24 | $ 16.96M |
| 3/31/2023 | $ 37.23M | 2.15 | $ 17.35M |
Key Performance Insights, Last 5 Years
- AVALO THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, AVALO THERAPEUTICS INC's average P/S has been 50.45.
- The median P/S for AVALO THERAPEUTICS INC during this period was 12.69
- AVALO THERAPEUTICS INC reached its highest P/S over the past 5 years at 249.03.
- The lowest P/S recorded by AVALO THERAPEUTICS INC in the same timeframe 0.24
AVALO THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for AVALO THERAPEUTICS INC is calculated as follows: Market Cap [ $ 154.31M ] / Revenues [ $ -3.52M ]
(=) P/S [ 0 ] AVTX - Price to Sales, Last 5 years
0.24
Minimum
Jun 30, 2023
249.03
Maximum
Jun 30, 2025
50.45
Average
12.69
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |